Water for Injection (WFI)

Water for Injection (WFI) designates highly purified water used in pharmaceutical manufacturing, particularly for preparation of parenteral products, cleaning of equipment, and formulation of sterile medicines where microbial and endotoxin control is essential. WFI meets stringent pharmacopeial requirements for chemical purity, microbial limits, and bacterial endotoxin levels, ensuring it is suitable for direct or indirect contact with products administered via injection.

The biopharmaceutical industry depends on WFI as a foundational utility across production facilities, especially for biologics, vaccines, and sterile injectables. WFI is used to prepare buffers, media, and process solutions, and it supports cleaning-in-place and sterilisation-in-place systems. Traditional WFI generation relies on distillation, which effectively removes impurities, microorganisms, and endotoxins. Increasingly, membrane-based technologies such as reverse osmosis combined with ultrafiltration are used where permitted by regulatory standards. WFI systems require rigorous qualification, monitoring, and maintenance to ensure ongoing compliance. Key parameters include conductivity, total organic carbon, microbial counts, and endotoxin levels, with routine sampling at defined points of use. Regulatory inspections closely assess WFI system design, monitoring programmes, and deviation management given the critical role of WFI in product safety.